Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Classical hematology 8 Gastrointestinal 4 Thoracic 2 Plasma cell 1 Lymphoid 1 Gynecologic 1 Genitourinary 1 CNS 1

Conditions

Multiple Myeloma 1 Lymphoma 1

Interventions

Rituximab 1371 Cyclophosphamide 1296 Vincristine 662 Doxorubicin 583 Etoposide 525 Prednisone 504 Cytarabine 481 fludarabine 461 Methotrexate 441 Dexamethasone 411 fludarabine phosphate 396 Lenalidomide 347 Filgrastim 342 Bendamustine Hydrochloride 274 Radiotherapy 266 venetoclax 254 ibrutinib 249 Peripheral Blood Stem Cell Transplantation 233 Melphalan 229 obinutuzumab 227 Granulocyte Colony-Stimulating Factor 212 Bortezomib 204 Gemcitabine 201 Busulfan 186 Whole-Body Irradiation 185 Mycophenolic Acid 174 Tacrolimus 164 Specimen Handling 161 Calcium Dobesilate 150 Magnetic Resonance Spectroscopy 149

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Tinzaparin × Lymphoid × Clear all

NCT02260414 2017-05-11

METRO B

Centre Hospitalier Universitaire de Saint Etienne

Phase 2 Completed

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡